Article
The Shifting Landscape of K<sub>Atp</sub>Channelopathies and the Need for ‘Sharper’ Therapeutics
1 May 2016
Abstract excerpt
ATP-sensitive potassium (KATP) channels play fundamental roles in the regulation of endocrine, neural and cardiovascular function. Small-molecule inhibitors (e.g., sulfonylurea drugs) or activators (e.g., diazoxide) acting on SUR1 or SUR2 have been used clinically for decades to manage the inappropriate secretion of insulin in patients with Type 2 diabetes, hyperinsulinism and intractable hypertension. More...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
